Wuhan Keqian Biology Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000042Q8
CNY
14.67
0.14 (0.96%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Wuhan Keqian Biology Co., Ltd.

Why is Wuhan Keqian Biology Co., Ltd. ?

1
With ROE of 10.26%, it has a very attractive valuation with a 2.01 Price to Book Value
  • Over the past year, while the stock has generated a return of 7.06%, its profits have risen by 34.2% ; the PEG ratio of the company is 0.6
  • At the current price, the company has a high dividend yield of 2.5
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Wuhan Keqian Biology Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Wuhan Keqian Biology Co., Ltd. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Wuhan Keqian Biology Co., Ltd.
-6.08%
0.02
28.31%
China Shanghai Composite
15.17%
1.58
14.20%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
6.94%
EBIT Growth (5y)
1.30%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.31
Sales to Capital Employed (avg)
0.25
Tax Ratio
13.25%
Dividend Payout Ratio
52.17%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
22.33%
ROE (avg)
12.82%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
2.01
EV to EBIT
16.08
EV to EBITDA
12.47
EV to Capital Employed
2.95
EV to Sales
6.09
PEG Ratio
0.57
Dividend Yield
2.45%
ROCE (Latest)
18.32%
ROE (Latest)
10.26%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -4.68% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 2.92 times

DEBTORS TURNOVER RATIO(HY)

Highest at 3.03 times

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS

Here's what is working for Wuhan Keqian Biology Co., Ltd.

Inventory Turnover Ratio
Highest at 2.92 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 3.03 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -4.68% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales